Updates are available Correction dated 2025-01-31
Click to view Correction: https://doi.org/10.1038/s41586-025-08653-4
-
Authors
Gu, Li https://orcid.org/0000-0001-5812-9024
Zhu, Yahui https://orcid.org/0000-0002-8138-0011
Nandi, Shuvro P. https://orcid.org/0000-0003-4855-4697
Lee, Maiya
Watari, Kosuke https://orcid.org/0000-0003-0260-2323
Bareng, Breanna
Ohira, Masafumi https://orcid.org/0000-0003-0775-3390
Liu, Yuxiao
Sakane, Sadatsugu https://orcid.org/0000-0002-6306-4621
Carlessi, Rodrigo https://orcid.org/0000-0003-0038-7391
Sauceda, Consuelo
Dhar, Debanjan
Ganguly, Souradipta
Hosseini, Mojgan
Teneche, Marcos G. https://orcid.org/0000-0003-4785-7987
Adams, Peter D. https://orcid.org/0000-0002-0684-1770
Gonzalez, David J.
Kisseleva, Tatiana
,
Tirnitz-Parker, Janina E. E.
Leedman, Peter J.
Wallace, Michael C.
Winteringham, Louise N.
Dwyer, Benjamin J.
Tibballs, Jonathan
Carter, Kim W.
Forrest, Alistair R. R.
Tirnitz-Parker, Janina E. E. https://orcid.org/0000-0002-3558-5892
Simon, M. Celeste https://orcid.org/0000-0001-9106-447X
Alexandrov, Ludmil B. https://orcid.org/0000-0003-3596-4515
Karin, Michael https://orcid.org/0000-0002-2758-6473
- License Information
-
More Information
Article History
Received: 22 July 2023
Accepted: 30 October 2024
First Online: 1 January 2025
Change Date: 31 January 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41586-025-08653-4
Competing interests
: M.K. is a founder and stockholder in Elgia Pharmaceuticals and received research support from Merck and Janssen Pharmaceuticals and holds a patent for the use of MUP-uPA mice as a NASH-HCC model. L.B.A. is a compensated consultant and has equity interest in io9 and Genome Insight; his spouse is an employee of Biotheranostics. L.B.A. is also listed as an inventor on US Patent 10,776,718 for source identification by non-negative matrix factorization. L.B.A. declares US provisional applications with the following serial numbers: 63/289,601, 63/269,033, 63/483,237, 63/366,392 and 63/367,846. L.B.A. and S.P.N. also declare US provisional applications with serial numbers 63/412,835 and 63/492,348. The other authors declare no competing interests.
